Neurable is a neurotechnology company focused on developing AI tools for brain signal translation and brain-computer interface technology.
Neurable has raised $35.0M in total funding. The most recent round was Series A. The last funding was announced in December 2025.
Neurable's investors include National Science Foundation, Global Brain Corporation, FundersClub, Innospark Ventures, Hartmann Capital.
Neurable is headquartered in Boston, United States.
Neurable is a neurotechnology company focused on developing AI tools for brain signal translation and brain-computer interface technology.
Neurable is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurable — Funding & Investors." VCBacked, December 19, 2025, https://www.vcbacked.co/company/neurable. Accessed October 31, 2026.
VCBacked. (2025). Neurable — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/neurable
{{cite web |title=Neurable — Funding & Investors |url=https://www.vcbacked.co/company/neurable |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated